We are live on ! Find out more
PRQR icon

ProQR Therapeutics
PRQR

37 hedge funds and large institutions have $162M invested in ProQR Therapeutics in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

0% more funds holding

Funds holding: 37 → 37 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

10% less capital invested

Capital invested by funds: $181M → $162M (-$18.4M)

Holders
37
Holders Change
–
Holders Change %
0%
% of All Funds
1.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
15
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HCMT
Highland Capital Management (Texas)
Texas
+$3.73M
2
CCP
Clough Capital Partners
Massachusetts
+$3.62M
3
RG
Redmile Group
California
+$2.41M
4
CCM
Century Capital Management
Massachusetts
+$901K
5
Millennium Management
Millennium Management
New York
+$887K

Top Sellers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
-$2.41M
2
EAM
EverPoint Asset Management
Connecticut
-$2.14M
3
SM
Sabby Management
Florida
-$1.02M
4
AC
Ascend Capital
California
-$869K
5
Asset Management One
Asset Management One
Japan
-$578K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$162K -$2.31K -138 -1%
SCM
27
Sterling Capital Management
North Carolina
$159K +$183K +10,911 New
Wells Fargo
28
Wells Fargo
California
$36K +$16.7K +1,000 +67%
Walleye Trading
29
Walleye Trading
New York
$28K +$31.8K +1,900 New
Deutsche Bank
30
Deutsche Bank
Germany
$27K -$389K -23,241 -92%
UBS Group
31
UBS Group
Switzerland
$18K +$15.1K +903 +301%
TRCT
32
Tower Research Capital (TRC)
New York
$13K +$7.1K +424 +89%
HHMI
33
Howard Hughes Medical Institute
Maryland
$12K +$3.53K +211 +35%
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$8K – – –
Creative Planning
35
Creative Planning
Kansas
$6K +$6.7K +400 New
EAM
36
EverPoint Asset Management
Connecticut
– -$2.14M -128,235 Closed
AC
37
Ascend Capital
California
– -$869K -52,235 Closed
Acadian Asset Management
38
Acadian Asset Management
Massachusetts
– -$303K -18,152 Closed
Renaissance Technologies
39
Renaissance Technologies
New York
– -$245K -14,697 Closed
SEP
40
Sound Energy Partners
Connecticut
– -$33K -2,000 Closed
CSS
41
Cubist Systematic Strategies
Connecticut
– -$16K -936 Closed
Point72 Asset Management
42
Point72 Asset Management
Connecticut
– -$2K -100 Closed
Citigroup
43
Citigroup
New York
– +$67 +4 New
1
2

PRQR Hedge Fund Activity: Q3 2015 in Review

37 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in ProQR Therapeutics (PRQR) for Q3 2015, worth a combined $162M — down 10% from $181M a quarter earlier.

Fund positioning in PRQR was balanced in Q3 2015: 7 funds opened new positions, 7 closed out, 15 added to existing stakes and 8 trimmed.

The largest buyer was Highland Capital Management (Texas), adding an estimated $3.73M. The largest seller was Janus Henderson Investors US, cutting an estimated $2.41M.

  • 37 institutional investors held ProQR Therapeutics (PRQR) as of Q3 2015, unchanged from Q2 2015.
  • Funds reported $162M of ProQR Therapeutics stock for Q3 2015, down 10% quarter-over-quarter.
  • 7 funds opened new ProQR Therapeutics positions in Q3 2015 and 7 closed out, a net change of 0 holders.
  • The largest ProQR Therapeutics buyer in Q3 2015 was Highland Capital Management (Texas), an estimated $3.73M added.
  • The largest ProQR Therapeutics seller in Q3 2015 was Janus Henderson Investors US, an estimated $2.41M sold.

Based on aggregated 13F filings for Q3 2015.